摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6-fluoro-3-hydroxy-2-(3,4,5-trimethoxyphenyl)-4H-chromen-4-one | 1394018-30-4

中文名称
——
中文别名
——
英文名称
6-fluoro-3-hydroxy-2-(3,4,5-trimethoxyphenyl)-4H-chromen-4-one
英文别名
6-fluoro-3',4',5'-trimethoxyflavonol;6-Fluoro-3-hydroxy-2-(3,4,5-trimethoxyphenyl)chromen-4-one
6-fluoro-3-hydroxy-2-(3,4,5-trimethoxyphenyl)-4H-chromen-4-one化学式
CAS
1394018-30-4
化学式
C18H15FO6
mdl
——
分子量
346.312
InChiKey
ZAUOVNJAOIUIRE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3
  • 重原子数:
    25
  • 可旋转键数:
    4
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.17
  • 拓扑面积:
    74.2
  • 氢给体数:
    1
  • 氢受体数:
    7

反应信息

点击查看最新优质反应信息

文献信息

  • Synthesis and biological evaluation of novel flavonols as potential anti-prostate cancer agents
    作者:Robert G. Britton、Emma Horner-Glister、Odette A. Pomenya、Ewan E. Smith、Roanne Denton、Paul R. Jenkins、William P. Steward、Karen Brown、Andreas Gescher、Stewart Sale
    DOI:10.1016/j.ejmech.2012.06.031
    日期:2012.8
    A library of flavonol analogues was synthesised and evaluated as potential anticancer agents against a human prostate cancer cell line, 22rv1. Compounds 3, 8 and 11 (IC50 2.6, 3.3 and 4.0 mu M respectively) showed potent cancer cell growth inhibition, comparable to the lead compound 3',4',5'-trimethoxyflavonol (1) (IC50 3.1 mu M) and superior to the naturally occurring flavonols quercetin (16) and fisetin (22) (both >15 mu M). Results indicate that the 3',4',5'- arrangement of either hydroxy (OH) or methoxy (OMe) residues is important for growth arrest of these cells and that the OMe analogues may be superior to their OH counterparts. Compounds 1, 3, 8 and 11 warrant further investigation as potential agents for the management of prostate cancer. (C) 2012 Elsevier Masson SAS. All rights reserved.
  • Synthesis, inverse docking-assisted identification and in vitro biological characterization of Flavonol-based analogs of fisetin as c-Kit, CDK2 and mTOR inhibitors against melanoma and non-melanoma skin cancers
    作者:Tithi Roy、Samuel T. Boateng、Sergette Banang-Mbeumi、Pankaj K. Singh、Pratik Basnet、Roxane-Cherille N. Chamcheu、Federico Ladu、Isabel Chauvin、Vladimir S. Spiegelman、Ronald A. Hill、Konstantin G. Kousoulas、Bolni Marius Nagalo、Anthony L. Walker、Jean Fotie、Siva Murru、Mario Sechi、Jean Christopher Chamcheu
    DOI:10.1016/j.bioorg.2020.104595
    日期:2021.2
查看更多